Beta-glucuronidase in sera of patients with epileptic seizure activity, diabetes and some other disease states.
As compared to controls and epileptics with controlled seizures, serum beta-glucuronidase enzyme is elevated significantly in epileptics with uncontrolled seizures. The enzyme begins to rise just before the seizure, remains elevated during, and for some time after the seizure and then begins to decline, unless another seizure follows the first seizure. The enzyme is not elevated in controlled diabetes patients without any secondary complications. But the enzyme is also elevated in other pathological conditions which involve increased connective tissue catabolism. However, the enzyme is elevated constantly and all the time in these conditions, in contrast with its elevation in uncontrolled epilepsy only close to the seizures.
D001921:Brain / Q000378:metabolism; D004796:Clinical Enzyme Tests; D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000188:drug therapy; D004827:Epilepsy / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism; D005966:Glucuronidase / Q000097:blood*; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000627:therapeutic use
D006025:Glycosaminoglycans; D007328:Insulin; D005966:Glucuronidase